Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Jaillon

Showing results (31-40 of 195) with videos related to

Pageof 20
Sort By:
Circulation|December 1, 1979
Electrophysiologic comparative study of procainamide and N-acetylprocainamide in anesthetized dogs: concentration-response relationshipsP Jaillon, R A Winkle
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1980
A model to describe myocardial drug disposition in the dogR E Kates, P Jaillon
La Revue Du Praticien|March 17, 1988
[The beta-adrenergic receptor and its physiology]P Jaillon, P Sauleman, A Rames
The American Journal of Cardiology|September 1, 1989
Physiologic relation between cardiac cycle and QT duration in healthy volunteersB Lecocq, V Lecocq, P Jaillon
Therapie|October 27, 2001
[Pharmaco-epidemiology: identification of needs, databases, and study quality criteria]M Vray, D Szafir, P Jaillon
Journal De Pharmacologie|April 1, 1982
[Cardiac electrophysiology study in the anesthetized dog]J Weissenburger, P Jaillon, J Hecklé
Therapie|March 1, 1976
[Pharmacokinetics of the principal anti-arrhythmic drugs. Measurement of their blood levels]G Cheymol, C Bernheim, P Jaillon
Therapie|July 1, 1997
[Pre-clinical and clinical electrophysiological studies for the prediction of iatrogenic proarrhythmic effect (torsade de pointes)]P Jaillon, B Dupuis, R Dahan
Fundamental & Clinical Pharmacology|May 5, 1999
Mibefradil, a potent CYP3A inhibitor, does not alter pravastatin pharmacokineticsL Becquemont, C Funck-Brentano, P Jaillon
Therapeutic Drug Monitoring|January 1, 1986
Quantitative liquid chromatographic determination of sotalol in human plasmaJ M Poirier, P Jaillon, G Cheymol
Pageof 20

Showing results (31-40 of 195) with videos related to

Sort By:
Pageof 20
Circulation|December 1, 1979
Electrophysiologic comparative study of procainamide and N-acetylprocainamide in anesthetized dogs: concentration-response relationshipsP Jaillon, R A Winkle
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1980
A model to describe myocardial drug disposition in the dogR E Kates, P Jaillon
La Revue Du Praticien|March 17, 1988
[The beta-adrenergic receptor and its physiology]P Jaillon, P Sauleman, A Rames
The American Journal of Cardiology|September 1, 1989
Physiologic relation between cardiac cycle and QT duration in healthy volunteersB Lecocq, V Lecocq, P Jaillon
Therapie|October 27, 2001
[Pharmaco-epidemiology: identification of needs, databases, and study quality criteria]M Vray, D Szafir, P Jaillon
Journal De Pharmacologie|April 1, 1982
[Cardiac electrophysiology study in the anesthetized dog]J Weissenburger, P Jaillon, J Hecklé
Therapie|March 1, 1976
[Pharmacokinetics of the principal anti-arrhythmic drugs. Measurement of their blood levels]G Cheymol, C Bernheim, P Jaillon
Therapie|July 1, 1997
[Pre-clinical and clinical electrophysiological studies for the prediction of iatrogenic proarrhythmic effect (torsade de pointes)]P Jaillon, B Dupuis, R Dahan
Fundamental & Clinical Pharmacology|May 5, 1999
Mibefradil, a potent CYP3A inhibitor, does not alter pravastatin pharmacokineticsL Becquemont, C Funck-Brentano, P Jaillon
Therapeutic Drug Monitoring|January 1, 1986
Quantitative liquid chromatographic determination of sotalol in human plasmaJ M Poirier, P Jaillon, G Cheymol
Pageof 20